In this issue:
Adding aspirin to warfarin with no apparent indication
Adjunctive intermittent pneumatic compression to prevent VTE
Andexanet alfa for factor Xa inhibitorassociated bleeding
Pembrolizumab for relapsed/ refractory mature T-cell lymphoma
First-line bendamustine/rituximab for indolent non-Hodgkin’s/mantle-cell lymphoma
DLI after haploidentical vs. matched-sibling SCT in very high-risk acute myeloid leukaemia
Toxicities in related vs. unrelated PBSC donors
Pegfilgrastim biosimilar for preventing chemotherapy-induced neutropenia
Eculizumab in PNH/atypical haemolytic uraemic syndrome
Please login below to download this issue (PDF)